Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice

被引:39
|
作者
Dantzer, R
Gheusi, G
Johnson, RW
Kelley, KW
机构
[1] INSERM, U394, INRA, Lab Integrat Neurobiol, F-33077 Bordeaux, France
[2] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA
关键词
behavior; brain; insulin-like growth factor-1; lipopolysaccharide; mice;
D O I
10.1097/00001756-199902050-00015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To assess the possible modulatory effects of insulin-like growth factor-1 (IGF-1) on the brain effects of proinflammatory cytokines, male CD-1 mice were injected into the lateral ventricle of the brain with a behaviorally depressing dose (100 ng) of the cytokine inducer lipopolysaccharide (LPS) and their response to various doses of IGF-1 (0, 100 and 1000 ng) was measured during behavioral tests carried before and at various time intervals after treatment. LPS induced a profound behavioral depression that was abrogated by the higher dose of IGF-1 tested. Since the behavioral effects of LPS are mediated by the local synthesis and results of proinflammatory cytokines, these results indicate that IGF-1 interferes with the production and/or action of proinflammatory cytokines in the brain. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:289 / 292
页数:4
相关论文
共 50 条
  • [41] Insulin, insulin-like growth factor-1, insulin receptor, and insulin-like growth factor-1 receptor expression in the chick eye and their regulation with imposed myopic or hyperopic defocus
    Penha, Alexandra Marcha
    Schaeffel, Frank
    Feldkaemper, Marita
    MOLECULAR VISION, 2011, 17 (162): : 1436 - 1448
  • [42] IGF1(Insulin-Like growth factor-1) as target antigen in NOD mice
    Keiichi, K
    Shimada, A
    Funae, O
    Morimoto, J
    Tokui, M
    Watanabe, K
    Saruta, T
    DIABETES, 2001, 50 : A261 - A261
  • [43] Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension
    Bartha, JL
    Romero-Carmona, R
    Torrejon-Cardoso, R
    Comino-Delgado, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (03) : 735 - 740
  • [44] Insulin and insulin-like growth factor-1 action on human skeletal muscle: Preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects
    Ciaraldi, TP
    Carter, L
    Rehman, N
    Mohideen, P
    Mudaliar, S
    Henry, RR
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (09): : 1171 - 1179
  • [45] Growth hormone, insulin-like growth factor-1 and the aging brain
    Ashpole, Nicole M.
    Sanders, Jessica E.
    Hodges, Erik L.
    Yan, Han
    Sonntag, William E.
    EXPERIMENTAL GERONTOLOGY, 2015, 68 : 76 - 81
  • [46] Role of Insulin-like Growth Factor-1 in the Regulation of Skeletal Growth
    Subburaman Mohan
    Chandrasekhar Kesavan
    Current Osteoporosis Reports, 2012, 10 : 178 - 186
  • [47] Role of Insulin-like Growth Factor-1 in the Regulation of Skeletal Growth
    Mohan, Subburaman
    Kesavan, Chandrasekhar
    CURRENT OSTEOPOROSIS REPORTS, 2012, 10 (02) : 178 - 186
  • [48] Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination
    Mason, JL
    Ye, P
    Suzuki, K
    D'Ercole, AJ
    Matsushima, GK
    JOURNAL OF NEUROSCIENCE, 2000, 20 (15): : 5703 - 5708
  • [49] Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
    Smith, John Kelly
    APPLIED SCIENCES-BASEL, 2020, 10 (13):
  • [50] Research questions concerning insulin-like growth factor-1
    Cradock A.L.
    Cancer Causes & Control, 2000, 11 (1) : 89 - 91